Total amount: € 0,00
Indexed/Abstracted in: BIOSIS Previews, EMBASE, Scopus, Emerging Sources Citation Index
Online ISSN 1827-1812
Incardona V. M., Dato E., Dato A. G.
Centro di Diagnostica Cardiovascolare del Dott. Dato Achille Giuseppe & C., Paternò, Catania, Italia
Calcific aortic valve disease (CAVD) is the most common acquired valvular disorder in developed countries. CAVD ranges from mild thickening of the valve, known as aortic valve sclerosis (AVSc), to severe impairment of the valve motion, which is termed aortic valve stenosis (AVS). The prevalence of aortic sclerosis without obstruction of the left ventricular outflow is present in nearly 30% of adults over 65 years of age. The pathophysiological development of CAVD is incompletely defined. The major methods to diagnose CAVD are clinical examination, echocardiography and cardiac catheterization. Biomarkers can give useful information about the presence, severity, progression and prognosis of CAVD. These markers provide the information necessary to optimize future therapeutic interventions.